Toshitaka Suzuki Selected Research

Micafungin (FK463)

11/2009

[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshitaka Suzuki Research Topics

Disease

1	Tuberculosis (Tuberculoses) 11/2018
1	Empyema 10/2018
1	Fistula 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Invasive Pulmonary Aspergillosis 11/2009
1	Pulmonary Aspergillosis 11/2009

Drug/Important Bio-Agent (IBA)

1	Hemoglobins (Hemoglobin)IBA 11/2018
1	C-Reactive ProteinIBA 11/2018
1	Serum AlbuminIBA 11/2018
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Albumin-Bound Paclitaxel FDA Link 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2009
1	Micafungin (FK463)FDA Link 11/2009

Therapy/Procedure

1	Nursing Care 11/2018
1	Gastrostomy 10/2018
1	Operative Surgical Procedures 10/2018
1	Radiotherapy 01/2016
1	Bronchoscopes 01/2011
1	Therapeutics 11/2009